Literature DB >> 20016174

Doxorubicin cardiomyopathy.

Kanu Chatterjee1, Jianqing Zhang, Norman Honbo, Joel S Karliner.   

Abstract

Established doxorubicin cardiomyopathy is a lethal disease. When congestive heart failure develops, mortality is approximately 50%. Extensive research has been done to understand the mechanism and pathophysiology of doxorubicin cardiomyopathy, and considerable knowledge and experience has been gained. Unfortunately, no effective treatment for established doxorubicin cardiomyopathy is presently available. Extensive research has been done and is being done to discover preventive treatments. However an effective and clinically applicable preventive treatment is yet to be discovered.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20016174      PMCID： PMC2848530          DOI： 10.1159/000265166

Source DB:  PubMed          Journal:  Cardiology        ISSN： 0008-6312            Impact factor:   1.869


  59 in total

1.  Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes.

Authors:  Satoshi Yamanaka; Tetsuya Tatsumi; Jun Shiraishi; Akiko Mano; Natsuya Keira; Satoaki Matoba; Jun Asayama; Shinji Fushiki; Henry Fliss; Masao Nakagawa
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

2.  A clinicopathologic analysis of adriamycin cardiotoxicity.

Authors:  E A Lefrak; J Pitha; S Rosenheim; J A Gottlieb
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

3.  Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia.

Authors:  X Thomas; Q H Le; D Fiere
Journal:  Ann Hematol       Date:  2002-09-21       Impact factor: 3.673

4.  Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis.

Authors:  C Huang; Z Zhang; M Ding; J Li; J Ye; S S Leonard; H M Shen; L Butterworth; Y Lu; M Costa; Y Rojanasakul; V Castranova; V Vallyathan; X Shi
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

5.  Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.

Authors:  O J Arola; A Saraste; K Pulkki; M Kallajoki; M Parvinen; L M Voipio-Pulkki
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

6.  The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.

Authors:  Steven E Lipshultz; Nader Rifai; Virginia M Dalton; Donna E Levy; Lewis B Silverman; Stuart R Lipsitz; Steven D Colan; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall A Schorin; Richard D Gelber; Stephen E Sallan
Journal:  N Engl J Med       Date:  2004-07-08       Impact factor: 91.245

7.  Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity.

Authors:  Anne Aries; Pierre Paradis; Chantal Lefebvre; Robert J Schwartz; Mona Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

8.  Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Authors:  Sandra M Swain; Fredrick S Whaley; Michael S Ewer
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

9.  Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis.

Authors:  Yuri Kim; Ai-Guo Ma; Kazumi Kitta; Sarah N Fitch; Takayuki Ikeda; Yoshiharu Ihara; Amy R Simon; Todd Evans; Yuichiro J Suzuki
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

Review 10.  Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.

Authors:  Giorgio Minotti; Pierantonio Menna; Emanuela Salvatorelli; Gaetano Cairo; Luca Gianni
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468
View more
  285 in total

1.  Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.

Authors:  Ana Ludke; Anita K Sharma; Ashim K Bagchi; Pawan K Singal
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

2.  Effect of oxidative stress on ventricular arrhythmia in rabbits with adriamycin-induced cardiomyopathy.

Authors:  Li He; Jianmin Xiao; Hui Fu; Guangsheng Du; Xing Xiao; Cuntai Zhang; Ye Gu; Yexin Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

3.  A Young Man with a Mediastinal Mass and Sudden Cardiac Arrest.

Authors:  Matthew W Vanneman; Karim Fikry; Sadeq A Quraishi; William Schoenfeld
Journal:  Ann Am Thorac Soc       Date:  2015-08

4.  Development of Liposomal Gemcitabine with High Drug Loading Capacity.

Authors:  Hassan Tamam; Jinho Park; Hytham H Gadalla; Andrea R Masters; Jelan A Abdel-Aleem; Sayed I Abdelrahman; Aly A Abdelrahman; L Tiffany Lyle; Yoon Yeo
Journal:  Mol Pharm       Date:  2019-06-14       Impact factor: 4.939

5.  Assessment of doxorubicin-induced mouse testicular damage by the novel second-harmonic generation microscopy.

Authors:  Chih-Chao Yang; Yen-Ta Chen; Chih-Hung Chen; John Y Chiang; Yen-Yi Zhen; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

6.  Titanium Plug Closure after HeartWare Ventricular Assist Device Explantation in a 15-Year-Old Girl: First U.S. Experience.

Authors:  Diego A Lara; Aamir Jeewa; Barbara A Elias; Elizabeth O McCullum; Susan W Denfield; William J Dreyer; Iki Adachi
Journal:  Tex Heart Inst J       Date:  2017-02-01

Review 7.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

8.  Differential Regulation of Bcl-xL Gene Expression by Corticosterone, Progesterone, and Retinoic Acid.

Authors:  Steve J Morrissy; Haipeng Sun; Jack Zhang; Joshua Strom; Qin M Chen
Journal:  J Biochem Mol Toxicol       Date:  2016-02-25       Impact factor: 3.642

9.  Inhibition of MMP prevents doxorubicin-induced cardiotoxicity by attenuating cardiac intracellular and extracellular matrix remodelling.

Authors:  Inna Rabinovich-Nikitin; Matthew Love; Lorrie A Kirshenbaum
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

10.  Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers.

Authors:  Rajiv Panwar; Prashant Bhattarai; Vishwesh Patil; Keyur Gada; Stan Majewski; Ban An Khaw
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.